Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diamine Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108794474B reveals novel evodiamine derivatives targeting Top1/Top2/HDAC. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Advanced sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine. Eliminates hazardous LiAlH4 reduction, ensuring >98% purity and safer industrial scale-up.
Novel synthesis of triazine hydroxyethyl ethylenediamine polycarboxylic acid using cyanuric chloride. Cost-effective rust inhibitor for industrial applications with superior stability.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN108530381B details a solvent-free method for diamine synthesis using saccharin. This offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110066233B details a high-yield cyclization method for mono-substituted amines, offering significant cost reduction in API manufacturing and superior impurity control.
Novel bis-evodiamine derivatives with enhanced antitumor activity and scalable synthesis routes for pharmaceutical intermediates supply chain optimization.
Patent CN102276376B introduces an efficient synthesis route eliminating chiral resolution, enhancing purity and reducing supply chain costs for pharmaceutical intermediates.